Elsewhere, TOP2A induced proliferation and metastasis of LUAD (Kou et al. 2020) and was linked to chemotherapy toxicity and survival in NSCLC patients (Grenda et al. 2020). Here, TOP2A is linked to non-small cell lung carcinoma.